RACE-2L: Real-World Assessment of Clinical Practice and Outcomes in Non-squamous NSCLC After Failure of Platinum-based Chemotherapy in Brazil
NCT06491862 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2026-05-22
Summary
The study will be implemented as a retrospective, noninterventional medical record review of patients from routine practice settings who have been diagnosed with a/m non-squamous NSCLC with or without AGA and received at least 1 line of systemic treatment after failing PTC between January 2017 and December 2024.
Conditions
- Non-squamous Non-Small Cell Lung Cancer
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-07-25
- Primary Completion
- 2026-06-30
- Completion
- 2026-06-30
Countries
- Brazil
Study Locations
More Related Trials
-
Retrospective Epidemiological Study of Locally Advanced Non Small Cell Lung Cancer Patients in Brazil
NCT03836469 ·Status: COMPLETED
-
A Study to See How Well and How Safely Different Treatments Work in a Group of Participants With Non-Small Cell Lung Cancer (NSCLC)
NCT06624059 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Non-Small Cell Lung Cancer (NSCLC)
NCT01024062 ·Status: COMPLETED ·Phase: PHASE2
-
Cisplatin/Irinotecan With Concurrent Radiation for Inoperable NSCLC
NCT02275806 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)
NCT04222972 ·Status: TERMINATED ·Phase: PHASE3
-
Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer: AIM-HIGH (Adjuvant Intervention in Molecular High Risk Patients)
NCT01817192 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Real-World Study on Adjuvant Therapy Combined With Shenlingcao Oral Liquid in Patients for Stage II and IIIA Non-small Cell Lung Cancer After Radical Resection
NCT03479294 ·Status: TERMINATED
-
AZD2014 and Weekly Paclitaxel in Squamous NSCLC
NCT02403895 ·Status: TERMINATED ·Phase: PHASE2
-
PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib
NCT00548093 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess Safety,Tolerability,Efficacy of PM01183 and Atezolizumab in Patients w/ Advanced Small Cell Lung Cancer.
NCT04253145 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study in Non-Small Cell Lung Cancer
NCT01232452 ·Status: COMPLETED ·Phase: PHASE2
-
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
NCT02154490 ·Status: COMPLETED
-
Atezolizumab Combined With Chemotherapy in Extensive Stage SCLC
NCT04920981 ·Status: COMPLETED
-
Observational Study of Patients With Locally Advanced or Metastatic NSCLC (Non-Small Cell Lung Cancer)
NCT03053297 ·Status: TERMINATED
-
An Observational Study on Patients With Non-Squamous NSCLC Who Reached A Long PFS After Avastin (Bevacizumab)-Based First-Line Therapy
NCT01343914 ·Status: COMPLETED
-
Patient-derived Tumor-like Cell Cluster Model-based Precision Treatment Strategy on Non-small Cell Lung Cancer
NCT07328945 ·Status: RECRUITING
-
A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC).
NCT00760929 ·Status: TERMINATED ·Phase: PHASE2
-
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
NCT04614103 ·Status: RECRUITING ·Phase: PHASE2
-
A Phase 2, Study of Ficlatuzumab Plus Erlotinib vs. Placebo Plus Erlotinib in Subjects With Previously Untreated Metastatic, EGFR-mutated NSCLC and BDX004 Positive Label
NCT02318368 ·Status: TERMINATED ·Phase: PHASE2
-
Randomized, Multi-center, Open-label, Study of PR104 Versus PR104/Docetaxel in Non-Small Cell Lung Cancer (NSCLC)
NCT00862134 ·Status: TERMINATED ·Phase: PHASE2
-
Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLC
NCT00001450 ·Status: COMPLETED ·Phase: PHASE2
-
Locally Advanced NSCLC Treated With Radiochemotherapy: Phase 2 Study on the Value of a Stereotactic Boost
NCT06627738 ·Status: RECRUITING ·Phase: PHASE2
-
Hypo-Hyperfractionated Chest Radiation for Non Small Cell Lung Cancer With Taxotere/Xeloda Combination Chemotherapy
NCT00256841 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
A Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/-Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted Therapies
NCT04042558 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized Study of Maintenance Therapy With MGN1703 in Patients With SCLC
NCT02200081 ·Status: COMPLETED ·Phase: PHASE2